Côte-d科特迪瓦慢性病毒性肝炎管理的社会经济方面

H. Anzouan-Kacou, Maire Dehinsala, A. Bangoura, D. H. Kouamé, Adjéka Stanislas Doffou, A. Mahassadi, F. B. Yao, A. Attia
{"title":"Côte-d科特迪瓦慢性病毒性肝炎管理的社会经济方面","authors":"H. Anzouan-Kacou, Maire Dehinsala, A. Bangoura, D. H. Kouamé, Adjéka Stanislas Doffou, A. Mahassadi, F. B. Yao, A. Attia","doi":"10.4314/aamed.v15i4.3","DOIUrl":null,"url":null,"abstract":"Context and objectives. Chronic viral hepatitis is a public health problem in Côte-d’Ivoire. A significant number of patients have little access to treatment due to the high costs of assessment and treatment. The objective of our study was to evaluate the costs of assessments and treatment of chronic viral hepatitis. Methods. This was an analytical cross-sectional observational study from March 1, 2019 to July 31, 2019 in the Hepato- Gastroenterology Consultation Service at the Yopougon University Hospital. The variables studied were socio-demographic and economic parameters. Results. 136 patients (men 53.6 %, average age 42 ± 12.2 years) were included. More than half of the patients (63.3 %) had a monthly income not exceeding 490.39 USD. The cost ofthe initial assessment was 223.13 USD and 351.14 USD for viral hepatitis B and C, respectively. Tenofovir and pegylated interferon were free of charge. Treatment with sofosbuvir + velpastavir cost 593.37 USD. The annual follow-up assessment was estimated at 237.02 USD for viral hepatitis B and 225.58 USD for viral hepatitis C. Conclusion. The assessment and treatment of chronic viral hepatitis have a cost that remains high for patients despite the universal health coverage.","PeriodicalId":31055,"journal":{"name":"Annales Africaines de Medecine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Socio-economic aspects of the management of chronic viral hepatitis in Côte-d’Ivoire\",\"authors\":\"H. Anzouan-Kacou, Maire Dehinsala, A. Bangoura, D. H. Kouamé, Adjéka Stanislas Doffou, A. Mahassadi, F. B. Yao, A. Attia\",\"doi\":\"10.4314/aamed.v15i4.3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Context and objectives. Chronic viral hepatitis is a public health problem in Côte-d’Ivoire. A significant number of patients have little access to treatment due to the high costs of assessment and treatment. The objective of our study was to evaluate the costs of assessments and treatment of chronic viral hepatitis. Methods. This was an analytical cross-sectional observational study from March 1, 2019 to July 31, 2019 in the Hepato- Gastroenterology Consultation Service at the Yopougon University Hospital. The variables studied were socio-demographic and economic parameters. Results. 136 patients (men 53.6 %, average age 42 ± 12.2 years) were included. More than half of the patients (63.3 %) had a monthly income not exceeding 490.39 USD. The cost ofthe initial assessment was 223.13 USD and 351.14 USD for viral hepatitis B and C, respectively. Tenofovir and pegylated interferon were free of charge. Treatment with sofosbuvir + velpastavir cost 593.37 USD. The annual follow-up assessment was estimated at 237.02 USD for viral hepatitis B and 225.58 USD for viral hepatitis C. Conclusion. The assessment and treatment of chronic viral hepatitis have a cost that remains high for patients despite the universal health coverage.\",\"PeriodicalId\":31055,\"journal\":{\"name\":\"Annales Africaines de Medecine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annales Africaines de Medecine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4314/aamed.v15i4.3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales Africaines de Medecine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/aamed.v15i4.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景和目标。慢性病毒性肝炎是Côte-d科特迪瓦的一个公共卫生问题。由于评估和治疗费用高昂,大量患者几乎无法获得治疗。本研究的目的是评估慢性病毒性肝炎的评估和治疗成本。方法。这是一项分析性横断面观察性研究,于2019年3月1日至2019年7月31日在Yopougon大学医院的肝脏-胃肠病学咨询服务中心进行。研究的变量是社会人口和经济参数。结果:共纳入136例患者(男性53.6%,平均年龄42±12.2岁)。超过一半(63.3%)的患者月收入不超过490.39美元。病毒性乙型肝炎和丙型肝炎的初始评估费用分别为223.13美元和351.14美元。替诺福韦和聚乙二醇干扰素是免费的。索非布韦+韦帕斯他韦治疗费用为593.37美元。乙型病毒性肝炎年度随访评估为237.02美元,丙型病毒性肝炎年度随访评估为225.58美元。尽管实现了全民健康覆盖,但慢性病毒性肝炎的评估和治疗费用仍然很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Socio-economic aspects of the management of chronic viral hepatitis in Côte-d’Ivoire
Context and objectives. Chronic viral hepatitis is a public health problem in Côte-d’Ivoire. A significant number of patients have little access to treatment due to the high costs of assessment and treatment. The objective of our study was to evaluate the costs of assessments and treatment of chronic viral hepatitis. Methods. This was an analytical cross-sectional observational study from March 1, 2019 to July 31, 2019 in the Hepato- Gastroenterology Consultation Service at the Yopougon University Hospital. The variables studied were socio-demographic and economic parameters. Results. 136 patients (men 53.6 %, average age 42 ± 12.2 years) were included. More than half of the patients (63.3 %) had a monthly income not exceeding 490.39 USD. The cost ofthe initial assessment was 223.13 USD and 351.14 USD for viral hepatitis B and C, respectively. Tenofovir and pegylated interferon were free of charge. Treatment with sofosbuvir + velpastavir cost 593.37 USD. The annual follow-up assessment was estimated at 237.02 USD for viral hepatitis B and 225.58 USD for viral hepatitis C. Conclusion. The assessment and treatment of chronic viral hepatitis have a cost that remains high for patients despite the universal health coverage.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
55
审稿时长
28 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信